ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer

被引:0
|
作者
Earl, Helena Margaret
Blenkinsop, C.
Grybowicz, L.
Vallier, A-L
Cameron, David A.
Bartlett, John M. S.
Murray, Nicholas
Caldas, Carlos
Thomas, J.
Dunn, Janet A.
Higgins, Helen B.
Hiller, Louise
Hayward, Larry
机构
[1] Univ Cambridge, Dept Oncol, Cambridge, England
[2] NIHR Cambridge Biomed Res Ctr, Cambridge, England
[3] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Canc Trials Ctr, Cambridge, England
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[6] Univ Edinburgh, Edinburgh Canc Res Ctr, Endocrine Canc Grp, Edinburgh, Midlothian, Scotland
[7] SA Hlth Author, Adelaide, SA, Australia
[8] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS1144
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Preoperative (neoadjuvant) chemotherapy in patients with breast cancer
    Mamounas, EP
    Fisher, B
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 389 - 399
  • [22] Experience with neoadjuvant chemotherapy in patients with breast cancer
    Zahid, Khawaja Farhan
    Siddique, Muhammad Kamran
    Siddiqui, Neelam
    Muzaffar, Narjis
    Asim, Muhammad
    Azfar, Muhammad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2010, 60 (04) : 284 - 287
  • [23] Neoadjuvant Chemotherapy in Patients with metaplastic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : 998 - 998
  • [24] RESULTS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
    Khorau, Anton
    BREAST, 2011, 20 : S51 - S51
  • [25] Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial
    Ali, H. R.
    Dariush, A.
    Thomas, J.
    Provenzano, E.
    Dunn, J.
    Hiller, L.
    Vallier, A. -L.
    Abraham, J.
    Piper, T.
    Bartlett, J. M. S.
    Cameron, D. A.
    Hayward, L.
    Brenton, J. D.
    Pharoah, P. D. P.
    Irwin, M. J.
    Walton, N. A.
    Earl, H. M.
    Caldas, C.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1832 - 1835
  • [26] Neoadjuvant chemotherapy for elderly breast cancer patients
    Brandao Matutino, A. Reis
    Silva Lima, J. M.
    Brito Silva, S.
    Vilas Boas, M.
    Oliveira Stephan, B.
    Van Vairsberg, V.
    Perez Fraile, N. Moreno
    Barroso-Sousa, R.
    Senna Mano, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S319 - S319
  • [27] Breast Cancer - Early Prediction of Success of neoadjuvant Chemotherapy
    不详
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2013, 185 (10): : 922 - 922
  • [28] Time trends of neoadjuvant chemotherapy for early breast cancer
    Riedel, Fabian
    Hoffmann, Ann Sophie
    Moderow, Mareike
    Heublein, Sabine
    Deutsch, Thomas M.
    Golatta, Michael
    Wallwiener, Markus
    Schneeweiss, Andreas
    Heil, Joerg
    Hennigs, Andre
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (11) : 3049 - 3058
  • [29] Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial
    Hornsby, Whitney E.
    Douglas, Pamela S.
    West, Miranda J.
    Kenjale, Aarti A.
    Lane, Amy R.
    Schwitzer, Emily R.
    Ray, Kaitlin A.
    Herndon, James E., II
    Coan, April
    Gutierrez, Antonio
    Hornsby, Kyle P.
    Hamilton, Erika
    Wilke, Lee G.
    Kimmick, Gretchen G.
    Peppercorn, Jeffrey M.
    Jones, Lee W.
    ACTA ONCOLOGICA, 2014, 53 (01) : 65 - 74
  • [30] Polychemotherapy for early breast cancer: Results from the international adjuvant breast cancer chemotherapy randomized trial
    不详
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07): : 506 - 515